PortfoliosLab logoPortfoliosLab logo
Zepp Health Corporation (ZEPP)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US98945L1052
CUSIP
98945L105
IPO Date
Feb 8, 2018

Highlights

Market Cap
$11.86M
Enterprise Value
$1.99B
EPS (TTM)
-$26.42
Total Revenue (TTM)
$1.84B
Gross Profit (TTM)
$709.81M
EBITDA (TTM)
-$187.05M
Year Range
$2.13 - $61.85
Target Price
$12.00
ROA (TTM)
-7.28%
ROE (TTM)
-19.17%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Zepp Health Corporation

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Zepp Health Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Zepp Health Corporation (ZEPP) has returned -55.64% so far this year and 303.72% over the past 12 months.


Zepp Health Corporation

1D
8.74%
1M
-38.02%
YTD
-55.64%
6M
-73.90%
1Y
303.72%
3Y*
31.63%
5Y*
-23.05%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 8, 2018, ZEPP's average daily return is +0.07%, while the average monthly return is +4.11%. At this rate, your investment would double in approximately 1.4 years.

Historically, 38% of months were positive and 62% were negative. The best month was Jul 2025 with a return of +406.0%, while the worst month was Mar 2026 at -38.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 9 months.

On a daily basis, ZEPP closed higher 45% of trading days. The best single day was Jul 11, 2025 with a return of +69.5%, while the worst single day was Mar 16, 2026 at -22.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-33.11%6.99%-38.02%-55.64%
20257.69%-4.64%10.86%-12.16%-2.50%4.93%406.02%234.32%1.73%-11.80%-33.26%-0.04%936.15%
2024-14.08%-7.38%-9.73%-17.65%-9.38%-21.18%-4.80%31.30%45.00%-26.21%-2.18%-17.20%-54.23%
202342.76%-18.36%-22.49%11.45%-19.18%-3.39%14.04%-16.92%6.48%-10.43%33.98%2.90%-2.07%
2022-1.39%-26.91%-18.20%-15.97%-15.70%-9.31%-5.95%9.77%-28.27%-10.22%-2.44%20.83%-70.31%
202115.70%20.57%-34.85%-4.64%-2.73%17.52%-5.11%-2.33%-26.19%2.24%-17.30%-25.63%-57.38%

Benchmark Metrics

Zepp Health Corporation has an annualized alpha of 4.16%, beta of 0.94, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since February 09, 2018.

  • This stock participated in 171.73% of S&P 500 Index downside but only 83.12% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
4.16%
Beta
0.94
0.05
Upside Capture
83.12%
Downside Capture
171.73%

Return for Risk

Risk / Return Rank

ZEPP ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


ZEPP Risk / Return Rank: 8989
Overall Rank
ZEPP Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
ZEPP Sortino Ratio Rank: 9494
Sortino Ratio Rank
ZEPP Omega Ratio Rank: 9090
Omega Ratio Rank
ZEPP Calmar Ratio Rank: 8989
Calmar Ratio Rank
ZEPP Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Zepp Health Corporation (ZEPP) and compare them to a chosen benchmark (S&P 500 Index).


ZEPPBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.98

0.90

+1.09

Sortino ratio

Return per unit of downside risk

3.41

1.39

+2.02

Omega ratio

Gain probability vs. loss probability

1.40

1.21

+0.19

Calmar ratio

Return relative to maximum drawdown

3.63

1.40

+2.23

Martin ratio

Return relative to average drawdown

7.22

6.61

+0.61

Explore ZEPP risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Zepp Health Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%1.00%2.00%3.00%4.00%5.00%6.00%7.00%$0.00$0.10$0.20$0.30$0.402022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022
Dividend$0.00$0.00$0.00$0.00$0.40

Dividend yield

0.00%0.00%0.00%0.00%6.90%

Monthly Dividends

The table displays the monthly dividend distributions for Zepp Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.40$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.40

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Zepp Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zepp Health Corporation was 97.30%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Zepp Health Corporation drawdown is 84.34%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.3%Feb 22, 2021869Aug 5, 2024
-61.54%Mar 4, 201963May 31, 2019434Feb 19, 2021497
-35.78%Jun 12, 201812Jun 27, 2018160Feb 15, 2019172
-26.37%Mar 6, 201835Apr 24, 201831Jun 7, 201866
-3.34%Feb 12, 201812Feb 28, 20183Mar 5, 201815

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Zepp Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Zepp Health Corporation is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ZEPP relative to other companies in the Scientific & Technical Instruments industry. Currently, ZEPP has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ZEPP in comparison with other companies in the Scientific & Technical Instruments industry. Currently, ZEPP has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items